Unknown PHASE3 INTERVENTIONAL 2-arm NCT01315821

Effect of Saccharomyces Boulardii on Necrotizing Enterocolitis in Very Low Birth Weight Infants

Role Of Saccharomyces Boulardii in Preventin Necrotizing Enterocolitis in Very Low Birth Weight Infants

Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital

Conditions Necrotizing Enterocolitis Very Low Birth Weight Infants

Interventions Placebo Saccharomyces boulardii

Updated 6 times since 2017 Last updated: Aug 4, 2011 Started: Feb 28, 2011 Primary completion: Dec 31, 2011 Completion: Dec 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Necrotizing Enterocolitis and Very Low Birth Weight Infants and is currently ongoing. Zekai Tahir Burak Women's Health Research and Education Hospital leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE3
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Feb 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Zekai Tahir Burak Women's Health Research and Education Hospital

Data source: Zekai Tahir Burak Women's Health Research and Education Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ankara, Turkey (Türkiye)